Blood Clots a Risk After Head, Neck Cancer Surgery
(Ivanhoe Newswire) –New research shows that there is an increased risk of venous thromboembolism (VTE, blood clot) in patients with head and neck cancer who are hospitalized after surgery and who are not routinely receiving anticoagulation therapy.
VTE is accountable for five to ten percent of all hospital deaths, and surgical cancer patients have a higher risk. For the study, researchers at Oregon Health and Science University, Portland, measured new cases of VTE within 30 days of surgery among patients hospitalized for at least four days. They found an overall incidence of VTE of 13 percent in a study of 100 patients who were hospitalized at a tertiary care academic medical center and underwent surgery to treat head and neck cancer.
Researchers also found that 14 percent of patients received some form of anticoagulation therapy and that bleeding complications in those patients were higher than in patients without anticoagulation therapy.
For more information, go to: http://media.jamanetwork.com/news-item/increased-risk-blood-clot-patients-head-neck-cancer-receiving-anticoagulation-therapy/
SOURCE: JAMA Otolaryngology-Head & Neck Surgery, September 2013
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.